Infectious Disease Genomics and Global Health: Abstract Deadline Extended

Having problems reading this? See a web version.
Infectious Disease Genomics and Global Health
1-3 October 2012

Abstract Deadline Extended: 18 August> Final abstracts and registrations are invited for the fifth Wellcome Trust/Cold Spring Harbor conference on Infectious Disease Genomics and Global Health.

The scientific organising committee encourage abstract submissions as the majority of the conference programme will be drawn from submitted abstracts. Genomic technologies promote cross-fertilisation amongst previously disparate fields, and we therefore welcome abstracts covering any area relevant to the genomics of infectious disease. Please note the abstract deadline has been extended until 18 August. For further details, abstract submission instructions and to register, please visit the conference website.

Scientific organisers
Matt Berriman (Wellcome Trust Sanger Institute, UK)
Jane Carlton (New York University, USA)
Julian Parkhill (Wellcome Trust Sanger Institute, UK)
George Weinstock (Washington University School of Medicine, USA)

Keynote speaker
Peter Hotez (Baylor College of Medicine, USA)
Scientia pro bono humani generis: OMICs in the pursuit of global health and poverty reduction

Epidemiology and public health
Janet Cox-Singh (University of St Andrews, UK)
Plasmodium knowlesi functional genomics – an opportunity to scrutinise malaria pathophysiology
Abdoulaye Djimde (University of Science, Techniques and Technology of Bamako, Mali)
Investigating a potential outbreak of cutaneous Leishmaniasis in Mali

Population genomics
Jonathan Juliano (University of North Carolina, USA)
Understanding within host diversity of Plasmodium falciparum using ultra deep sequencing
Christophe Fraser (Imperial College London, UK)
Predicting multi-drug resistance in the pneumococcus: a co-existential crisis

Parasites and vectors
Chris Plowe (University of Maryland School of Medicine, USA)
Genome-wide studies of clinical resistance of Plasmodium falciparum to artemisinins
Joanne Webster (Imperial College London, UK)
Schistosomiasis in a changing world

Bacteria
Sharon Peacock (University of Cambridge, UK)
Using bacterial genomics to improve global health: opportunities and obstacles
Sebastien Gagneux (Swiss Tropical & Public Health Institute, Switzerland)
Evolutionary forces in Mycobacterium tuberculosis: impact on global control efforts

Neglected tropical diseases
Serap Aksoy (Yale School of Public Health, USA)
Host dependence on symbiome functions: tsetse flies and trypanosome transmission
Sam Kariuki (KEMRI, Kenya)
Endemic tropical disease outbreaks in Africa: application of genomics to our understanding epidemiology and options for targeted control

Viruses
Ian Lipkin (Columbia University, USA)
Microbe hunting in the 21st century
Elodie Ghedin (University of Pittsburgh, USA)
Comparative genomics of virus emergence and transmission

For your diary
Registration deadline: 3 September

Please note: owing to building work at Hinxton, this year’s conference will take place at the Møller Centre, Churchill College – part of the historic University of Cambridge.

Our full events poster is also available for download and updates can be followed on Twitter. Please feel free to forward this information to your colleagues, who can sign up for our regular updates here.

For further information please contact coursesandconfs To unsubscribe from future Scientific Conference updates, email us at coursesandconfs
with the subject line ‘Unsubscribe’.
To unsubscribe from all Wellcome Trust communications click here.
The Wellcome Trust is a charity registered in England and Wales, no. 210183. Its sole trustee is The Wellcome Trust Limited, a company registered in England and Wales, no. 2711000 (whose registered office is at 215 Euston Road, London NW1 2BE, UK)

Yes Virginia, even the cervix has a #microbiome ……….. or does it?

Just read over the following paper: PLoS ONE: The Cervical Microbiome over 7 Years and a Comparison of Methodologies for Its Characterization

It is interesting and has lots of tidbits worth looking at in more detail including

  • An analysis of methods for classifying sequence reads as to which organism they likely come from
  • comparison of amplification and sequencing methods
  • long time period covered in the sampling
  • and much more
But what struck me more than anything is that, well, they referred to the microbial community that they were sampling as the “cervical microbiome.”  And though what they discuss here is fascinating in many ways, I am beginning to wonder if every site on the human body (or sites on other organisms) should have its own microbiome.    Or, another way of looking at this is – where do we draw the line between niches?  Is there a eyebrow microbiome?  A left elbow microbiome?  A testicle microbiome?  Certainly, I view the microbes that live in and on people as part of an ecosystem.  But I think just as biomes in the world around us should be defined by – well – something bigger than just GPS coordinates – so too microbiomes should probably be a bit bigger than just the microbes found in a particular body site.  Starting to wonder if we are going to see a proliferation of microbiomes just as we have seen a proliferation of OMIC words.  Ooh — this could give me something new to give an award for.  

My Tree of Life doodle on our food container from dinner at Seasons in #DavisCa

P537

William Shatner, Mars, Curiosity, Rover … fun fun fun

William Shatner narrates video detailing how Curiosity will land on Mars next week http://cdn-akm.vmixcore.com/vmixcore/js?auto_play=0&cc_default_off=1&player_name=uvp&width=512&height=332&player_id=1aa0b90d7d31305a75d7fa03bc403f5a&t=V0xL7FpdMBTgI9wbokivyCDQbYr3dNMyMc Hat tip to Dawn Sumner, UC Davis Geology professor working on Curiosity mission, for pointing me to this. Don’t like that? Well, here is a narration by Wil Wheaton http://cdn-akm.vmixcore.com/vmixcore/js?auto_play=0&cc_default_off=1&player_name=uvp&width=512&height=332&player_id=1aa0b90d7d31305a75d7fa03bc403f5a&t=V0J_fCVbhIlC6m5frWM2NxUQEaE4C8GCK_

Posts from #microBEnet that may be of interest

Quick post here – posting links to recent blog posts on the microBEnet blog that may be of interest here.  The microBEnet blog is part of the microBEnet project that I run on microbiology of the built environment.

Episode of Radio New Zealand "This Way Up": "Meet your microbes" discussion w/ me

Did an interview over the phone with Simon Morton for Radio New Zealand’s “This Way Up.”  Discussing microbial diversity and in part as a follow up on my TEDMED/TED talk.

Not a #badomics word but – "Evolutionary Systems Biology" is – well – pretty complex

Just saw the title of this article Evolutionary Systems Biology: Historical and Philosophical Perspectives on an Emerging Synthesis by Maureen A. O’Malley in Advances in Experimental Medicine and Biology, 2012, Volume 751, 1-28, DOI: 10.1007/978-1-4614-3567-9_1.  And my first thought was “Hmmm – WTF is Evolutionary Systems Biology“.  Given that I am still unsure what Systems Biology is exactly I figured – this could be a doozy.  Thus I perused the abstract:

According to the abstract

Systems biology (SB) is at least a decade old now and maturing rapidly. A more recent field, evolutionary systems biology (ESB), is in the process of further developing system-level approaches through the expansion of their explanatory and potentially predictive scope. This chapter will outline the varieties of ESB existing today by tracing the diverse roots and fusions that make up this integrative project. My approach is philosophical and historical. As well as examining the recent origins of ESB, I will reflect on its central features and the different clusters of research it comprises. In its broadest interpretation, ESB consists of five overlapping approaches: comparative and correlational ESB; network architecture ESB; network property ESB; population genetics ESB; and finally, standard evolutionary questions answered with SB methods. After outlining each approach with examples, I will examine some strong general claims about ESB, particularly that it can be viewed as the next step toward a fuller modern synthesis of evolutionary biology (EB), and that it is also the way forward for evolutionary and systems medicine. I will conclude with a discussion of whether the emerging field of ESB has the capacity to combine an even broader scope of research aims and efforts than it presently does.

I am not sure what to say here.  The author has published some interesting work previously on philosophical issues in biology.   But from the abstract – well – I am pretty lost.  It seems that ESB covers a lot of ground.  First – systems biology – whatever it means –  itself is pretty broad.  And then on top of that, ESB apparently covers even more than SB.  Still not sure what ESB is — I am torn about whether it could be interesting or completely flaky.  I am (as many know) a big fan of adding evolutionary approaches to just about any area of biology.  So that alone makes me think about reading the paper to see whether there is any there there.  But alas, I do not have access, so I am going to have to move on to something else.


Some comments from the web on this paper

https://twitter.com/caseybergman/status/229477100069978112

Future of the human microbiome project (HMP) at NIH?

Just got this question by email

“Dear Professor Eisen, I wonder if you can shed any light on the question whether the Human Microbiome Project will be renewed or if it is being discontinued at NIH. I happened to thumb through (on a Kindle) the 2013 proposed budget for the NIH Common Fund to find to my astonishment that the HMP — which had been lionized in June and July in issues of Nature and Science and PLoS — has been apparently zeroed out. The Budget narrative states bleakly: “The FY 2013 President’s Budget request of $1.207 million for HMP represents a decrease of $22.531 million, or 94.92 percent less than the FY 2012 level. The estimated decrease in funding reflects the planned FY 2012 conclusion of all but one of the awards. This award had a late start, and therefore will continue into FY 2013. There is a possibility of supporting a second phase of the HMP program, pending an analysis of current needs.” If you go on the HMP website, you will see that all the program RFPs have been archived under the statement “There are no funding opportunities at this time.” (See http://commonfund.nih.gov/hmp/grants.aspx). I am an avid follower of your Tree of life Blog. Thank you for running it. I imagine other readers might also be interested in what is going on with respect to the HMP budget. “

Interesting question.  Here is what I know which is very limited.

  • The NIH Human Microbiome Project was funded as a “Roadmap” initiative.  
    • “The Human Microbiome Project is part of the NIH Roadmap for Medical Research. The Roadmap is a series of initiatives designed to pursue major opportunities and gaps in biomedical research that no single NIH institute could tackle alone, but which the agency as a whole can address to make the biggest impact possible on the progress of medical research. Additional information about the NIH Roadmap can be found at http://www.nihroadmap.nih.gov.”
    • It was a five year program, starting in 2007 and ending in 2012. 
  • The full details of the 2013 NIH budget request are here
  • In 2013 testimony by NIH at congress the HMP is discussed
    • “One fascinating area of basic research is the Human Microbiome Project, an initiative supported through the NIH Common Fund. This project is giving us wonderful insights into the sweeping range of bacteria that live on and in each of us, and is expanding our knowledge about the role of these microbial communities in health and disease. Recent scientific evidence suggests that changes in the composition and activity of the human microbiome may contribute to obesity, which may provide us with new ways of addressing this serious threat to our nation’s health.”
I have heard discussions about how NIH might try to do another round of funding for the HMP but I do not know where this stands.  If anyone out there knows anything else — please post.

Best #human #microbiome item of week: #MinaBissellToo #Cancer #TED

From Science Friday.

My wife just told me about a fascinating Science Friday episode that I missed today: Building Organs, On One Microchip At A Time : NPR.  The discussion was with Dr. Donald Ingber from Harvard who has been designing mock organ systems with microchips.

Of particular relevance to microbiome studies are the following sections

“One example was that we put human intestinal cells that have been studied and cultured for years, and the pharmaceutical companies actually use them for looking at absorption in dishes, but everybody knows they’re not very good. They don’t really mimic gut function. When we put them in our chip and when we give them peristaltic-like undulating stretching rhythmically and we trickle flow over them like in your gut, they start forming villi, which are like the finger-like projections that increase surface area for absorption in your intestine. 

And what really surprised me is that the proliferative cells, the cells that are dividing rapidly, are in the crypt, the bottom – like between your fingers, at the bottom of these fingers, which is exactly like in your intestine. Plus, they put out mucus on the top of it, which protects it, and now we can put microbes on top. If you put microbes – if you put bacteria on cells in a dish, we call it contamination, and you have to throw it out and sterilize it. But we put microbes on the top and they’re perfectly happy. They’re symbiotic. And this is important because – and I don’t know if your show highlighted it, but over the last few months there’s been a lot of news that the microbiome – the microorganisms that live in our body can be very important for various diseases. And so we now have ways to study that. And the microbiome in the human is different than the mouse. And so this is very exciting for new opportunities.”

And then later

And I think other groups are looking at, you know, viral infections, for example. With our gut-on-a-chip, we’re hoping to study Crohn’s disease. Where it’s known in Crohn’s disease, there are three major contributors. One is inflammation, and we could add white blood cells, for example. The other is the microbiome, the microbes living in the gut. The other is peristaltic-like motions – again, mechanics. And so we can control all three of those.

Now I am sure there is some excessive enthusiasm for the power of their chip system here.  But it is fascinating and certainly will have many uses for testing models of function of host-microbe interacting systems.

The part I find most fascinating has nothing per se to do with the gut – what is most interesting is the concept that mechanical forces are fundamentally important to cell and organ function, development and regulation.  Here is one portion of what Ingber said:

We, you know, we actually – I’ve worked for 35 years in a strange – from a strange perspective in biology in that I’ve been – I was convinced that mechanical forces, that the forces due to breathing-like motions and stretching, you know, your muscles and the pulsations of blood through your vessels, that the stretching and the relaxing, the mechanical stresses are as important for regulating cell and tissue function as chemicals in genes. This is now getting more accepted in biology, but because of that, I felt that we had to create microenvironments that could mimic that – we had to develop microchips that can mimic that microenvironment. And what we ‘re finding consistently is that cells that people used before that they didn’t think were very good are now recapitulating organ-like functions. 

And as I said at a meeting yesterday, you know, there are no bad cells, just like there are no bad kids. There are bad families. There are bad neighborhoods and so forth. But – and so you have to give it the right microenvironment. We’ve also – I guess another surprising thing in the lung – and this was surprising – is that not only did we mimic complex functions such as the entire inflammatory response if we put a bacteria in the airspace in our little breathing lung on a chip, we saw in human, white blood cells stick to the vessel migrate across and engulf them. And that is something we hope for. 

But when we started to do things like we looked at toxicities of airborne particulates like in smog, we found that they were absorbed across the airspace to the vessel, which was great, but we found that breathing motions, physiological breathing motions increase the efficiency of that by tenfold. Now that no one’s even thought of before, nor have I. And so that was a prediction. And then we went back to animal models where we could control ventilation and we found exactly the same thing.

I have been thinking a lot about mechanical focuses and biology recently – especially since Mina Bissell came to visit UC Davis last year.  I wrote about her visit here: Mina Bissell, another of my science heroes, returns to #UCDavis (and also about her last visit before that here — The Tree of Life: A eureka moment – but not of the good kind).  Mina has been focused on how mechanical forces are critical to cancer development.  The best way to learn about Mina’s obsession is to watch one of her talks such as one that was recently posted at TED.

http://video.ted.com/assets/player/swf/EmbedPlayer.swf

In the era of genomics and other ones the importance of mechanical forces and local environment has been ignored by many.  But it shouldn’t be.  When I was a graduate student at Stanford, one professor there – Paul Green – was completely obsessed by mechanical forces and their effects of biological systems.  Sadly – Paul – who was an amazing teacher and person – died of pancreatic cancer just as I was finishing my PhD.  But every time I see something about mechanical forces I think of him and I think he would have really enjoyed this Science Friday as well as Bissell’s work.

Ongoing notes from #BigData meeting at #ucdavis

Note Jul 26, 2012.pdf
Sent from my iPad